FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2038167412> ?p ?o ?g. }

• W2038167412 endingPage "676" @default.
• W2038167412 startingPage "670" @default.
• W2038167412 abstract "Objective:Improved health outcomes can result in economic savings for hospitals and payers. While effectiveness of topical hemostatic agents in cardiac surgery has been demonstrated, evaluations of their economic benefit are limited. This study quantifies the cost consequences to hospitals, based on clinical outcomes, from using a flowable hemostatic matrix vs non-flowable topical hemostatic agents in cardiac surgery.Research design and methods:Applying clinical outcomes from a prospective randomized clinical trial, a cost consequence framework was utilized to model the economic impact of comparator groups. From that study, clinical outcomes were obtained and analyzed for a flowable hemostatic matrix (FLOSEAL, Baxter Healthcare Corporation) vs non-flowable topical hemostats (SURGICEL Nu-Knit, Ethicon–Johnson & Johnson; GELFOAM, Pfizer). Costing analyses focused on the following outcomes: complications, blood transfusions, surgical revisions, and operating room (OR) time. Cardiac surgery costs were analyzed and expressed in 2012 US dollars based on available literature searches and US data. Comparator group variability in cost consequences (i.e., cost savings) was calculated based on annualized impact and scenario testing.Results:Results suggest that if a flowable hemostatic matrix (rather than a non-flowable hemostat) was utilized exclusively in 600 mixed cardiac surgeries annually, a hospital could improve patient outcomes by a reduction of 33 major complications, 76 minor complications, 54 surgical revisions, 194 transfusions, and 242 h of OR time. These outcomes correspond to a net annualized cost consequence savings of $5.38 million, with complication avoidance as the largest contributor.Conclusions:This cost consequence framework and supportive modeling was used to evaluate the hospital economic impact of outcomes resulting from the usage of various hemostatic agents. These analyses support that cost savings can be achieved from routine use of a flowable hemostatic matrix, rather than a non-flowable topical hemostat, in cardiac surgery." @default.
• W2038167412 created "2016-06-24" @default.
• W2038167412 creator A5019067234 @default.
• W2038167412 creator A5022444018 @default.
• W2038167412 creator A5046916138 @default.
• W2038167412 creator A5079624735 @default.
• W2038167412 creator A5085007557 @default.
• W2038167412 date "2014-06-20" @default.
• W2038167412 modified "2023-09-25" @default.
• W2038167412 title "Hospital economic impact from hemostatic matrix usage in cardiac surgery" @default.
• W2038167412 cites W1964789171 @default.
• W2038167412 cites W1994883270 @default.
• W2038167412 cites W2022367227 @default.
• W2038167412 cites W2027685298 @default.
• W2038167412 cites W2053821268 @default.
• W2038167412 cites W2087373046 @default.
• W2038167412 cites W2087789613 @default.
• W2038167412 cites W2088464797 @default.
• W2038167412 cites W2091817958 @default.
• W2038167412 cites W2092143682 @default.
• W2038167412 cites W2095359248 @default.
• W2038167412 cites W2096876696 @default.
• W2038167412 cites W2102396208 @default.
• W2038167412 cites W2107066042 @default.
• W2038167412 cites W2155676244 @default.
• W2038167412 cites W2264968330 @default.
• W2038167412 doi "https://doi.org/10.3111/13696998.2014.928638" @default.
• W2038167412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24927164" @default.
• W2038167412 hasPublicationYear "2014" @default.
• W2038167412 type Work @default.
• W2038167412 sameAs 2038167412 @default.
• W2038167412 citedByCount "15" @default.
• W2038167412 countsByYear W20381674122015 @default.
• W2038167412 countsByYear W20381674122017 @default.
• W2038167412 countsByYear W20381674122018 @default.
• W2038167412 countsByYear W20381674122019 @default.
• W2038167412 countsByYear W20381674122020 @default.
• W2038167412 countsByYear W20381674122021 @default.
• W2038167412 countsByYear W20381674122022 @default.
• W2038167412 countsByYear W20381674122023 @default.
• W2038167412 crossrefType "journal-article" @default.
• W2038167412 hasAuthorship W2038167412A5019067234 @default.
• W2038167412 hasAuthorship W2038167412A5022444018 @default.
• W2038167412 hasAuthorship W2038167412A5046916138 @default.
• W2038167412 hasAuthorship W2038167412A5079624735 @default.
• W2038167412 hasAuthorship W2038167412A5085007557 @default.
• W2038167412 hasBestOaLocation W20381674121 @default.
• W2038167412 hasConcept C126322002 @default.
• W2038167412 hasConcept C141071460 @default.
• W2038167412 hasConcept C144133560 @default.
• W2038167412 hasConcept C160735492 @default.
• W2038167412 hasConcept C162324750 @default.
• W2038167412 hasConcept C162853370 @default.
• W2038167412 hasConcept C164624739 @default.
• W2038167412 hasConcept C168563851 @default.
• W2038167412 hasConcept C177713679 @default.
• W2038167412 hasConcept C194828623 @default.
• W2038167412 hasConcept C2777552930 @default.
• W2038167412 hasConcept C2778589496 @default.
• W2038167412 hasConcept C2778789114 @default.
• W2038167412 hasConcept C2909810335 @default.
• W2038167412 hasConcept C50522688 @default.
• W2038167412 hasConcept C535046627 @default.
• W2038167412 hasConcept C71924100 @default.
• W2038167412 hasConceptScore W2038167412C126322002 @default.
• W2038167412 hasConceptScore W2038167412C141071460 @default.
• W2038167412 hasConceptScore W2038167412C144133560 @default.
• W2038167412 hasConceptScore W2038167412C160735492 @default.
• W2038167412 hasConceptScore W2038167412C162324750 @default.
• W2038167412 hasConceptScore W2038167412C162853370 @default.
• W2038167412 hasConceptScore W2038167412C164624739 @default.
• W2038167412 hasConceptScore W2038167412C168563851 @default.
• W2038167412 hasConceptScore W2038167412C177713679 @default.
• W2038167412 hasConceptScore W2038167412C194828623 @default.
• W2038167412 hasConceptScore W2038167412C2777552930 @default.
• W2038167412 hasConceptScore W2038167412C2778589496 @default.
• W2038167412 hasConceptScore W2038167412C2778789114 @default.
• W2038167412 hasConceptScore W2038167412C2909810335 @default.
• W2038167412 hasConceptScore W2038167412C50522688 @default.
• W2038167412 hasConceptScore W2038167412C535046627 @default.
• W2038167412 hasConceptScore W2038167412C71924100 @default.
• W2038167412 hasIssue "9" @default.
• W2038167412 hasLocation W20381674121 @default.
• W2038167412 hasLocation W20381674122 @default.
• W2038167412 hasOpenAccess W2038167412 @default.
• W2038167412 hasPrimaryLocation W20381674121 @default.
• W2038167412 hasRelatedWork W1971224117 @default.
• W2038167412 hasRelatedWork W2019402723 @default.
• W2038167412 hasRelatedWork W2027685298 @default.
• W2038167412 hasRelatedWork W2041630461 @default.
• W2038167412 hasRelatedWork W2051367795 @default.
• W2038167412 hasRelatedWork W2179242480 @default.
• W2038167412 hasRelatedWork W2394820454 @default.
• W2038167412 hasRelatedWork W2412132252 @default.
• W2038167412 hasRelatedWork W2415508940 @default.
• W2038167412 hasRelatedWork W2617906316 @default.
• W2038167412 hasVolume "17" @default.
• W2038167412 isParatext "false" @default.

• next